Breaking News Instant updates and real-time market news.

GBTC

Bitcoin Investment Trust

$0.00 /

+ (+0.00%)

09:19
01/21/20
01/21
09:19
01/21/20
09:19

Grayscale Bitcoin Trust becomes SEC reporting company

Grayscale Investments, the world's largest digital currency asset manager and sponsor of Grayscale Bitcoin Trust announced that the Registration Statement on Form 10 that it filed with the Securities and Exchange Commission on behalf of the Trust has been deemed effective. The Trust is now an SEC reporting company with its shares registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended. The Trust is solely and passively invested in Bitcoin, enabling investors to gain exposure to Bitcoin in the form of a security while avoiding the challenges of buying, storing, and safekeeping Bitcoin directly. Now, it is also the first digital currency investment vehicle to attain the status of an SEC reporting company. Additionally, accredited investors who own or purchase shares from the Trust's private placement now have an earlier liquidity opportunity as the statutory holding period of shares purchased through the private placement will be reduced from 12 months to 6 months, provided the other requirements under Rule 144 of the Securities Act of 1933, as amended have been satisfied.

TODAY'S FREE FLY STORIES

Conference/Events
IMV Inc. to host conference call » 07:25
02/25/20
02/25
07:25
02/25/20
07:25
IMV

IMV Inc.

$4.77 /

+ (+0.00%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Freshpet to host investor day » 07:25
02/25/20
02/25
07:25
02/25/20
07:25
FRPT

Freshpet

$73.68 /

-0.46 (-0.62%)

Investor day to be held…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
JPMorgan to host investor day » 07:25
02/25/20
02/25
07:25
02/25/20
07:25
JPM

JPMorgan

$132.16 /

-3.65 (-2.69%)

Investor day to be held…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Intercept reports Q4 EPS ($2.99), consensus ($2.67 » 07:24
02/25/20
02/25
07:24
02/25/20
07:24
ICPT

Intercept

$90.77 /

-4.24 (-4.46%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Healthpeak management to meet with RBC Capital » 07:24
02/25/20
02/25
07:24
02/25/20
07:24
PEAK

Healthpeak

$37.12 /

-0.035 (-0.09%)

Meeting to be held in New…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Realogy renames operating segments » 07:23
02/25/20
02/25
07:23
02/25/20
07:23
RLGY

Realogy

$12.88 /

-0.23 (-1.75%)

, BID

Sotheby's

$0.00 /

+ (+0.00%)

Realogy announced a new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
HP Inc. upgraded to Buy from Hold at Loop Capital » 07:23
02/25/20
02/25
07:23
02/25/20
07:23
HPQ

HP Inc.

$22.13 /

-0.55 (-2.43%)

, XRX

Xerox

$34.90 /

-1.45 (-3.99%)

Loop Capital analyst…

Loop Capital analyst Ananda Baruah upgraded HP Inc. (HPQ) to Buy from Hold with a price target of $28, up from $19. The stock closed Monday down 60c to $22.10. The company's earnings call included a handful of announcements that suggest the stock "continues to move higher from here through various means," Baruah tells investors in a research note. These include HP's new buyback as well as an incremental cost saves plan that places 2022 earnings per share at $3.25, says the analyst. Further, Baruah notes that HP stated it would be contacting Xerox (XRX) to see if a deal could be reached that appropriately rewards its shareholders.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Evolus reports Q4 EPS (47c), consensus (73c) » 07:22
02/25/20
02/25
07:22
02/25/20
07:22
EOLS

Evolus

$9.35 /

-0.89 (-8.69%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Home Depot outlook affirmed with upside bias seen, says Baird » 07:21
02/25/20
02/25
07:21
02/25/20
07:21
HD

Home Depot

$239.77 /

-5.56 (-2.27%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Palo Alto Networks price target lowered to $240 from $275 at Wedbush » 07:21
02/25/20
02/25
07:21
02/25/20
07:21
PANW

Palo Alto Networks

$236.99 /

-5.87 (-2.42%)

Wedbush analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Intuit price target raised to $320 from $303 at BofA » 07:20
02/25/20
02/25
07:20
02/25/20
07:20
INTU

Intuit

$286.50 /

-11.27 (-3.78%)

BofA analyst Kash Rangan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Montage Resources reports Q4 net production averaged 623.4 MMcfe per day » 07:19
02/25/20
02/25
07:19
02/25/20
07:19
MR

Montage Resources

$3.39 /

-0.255 (-7.00%)

Net production for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Chimerix expects to submit BCV NDA for smallpox in mid-2020 » 07:19
02/25/20
02/25
07:19
02/25/20
07:19
CMRX

Chimerix

$1.75 /

+0.025 (+1.45%)

In January, Chimerix…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Dine Brands price target raised to $110 from $100 at Wedbush » 07:18
02/25/20
02/25
07:18
02/25/20
07:18
DIN

Dine Brands

$96.06 /

-1.13 (-1.16%)

Wedbush analyst Nick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Chimerix to initiate Phase 3 trial of DSTAT w/ chemotherapy mid-year » 07:18
02/25/20
02/25
07:18
02/25/20
07:18
CMRX

Chimerix

$1.75 /

+0.025 (+1.45%)

Chimerix recently…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
United Airlines' long-term opportunity remains, says BofA » 07:17
02/25/20
02/25
07:17
02/25/20
07:17
UAL

United Airlines

$75.46 /

-2.56 (-3.28%)

BofA analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Duke Realty management to meet with SunTrust » 07:17
02/25/20
02/25
07:17
02/25/20
07:17
DRE

Duke Realty

$37.71 /

-1.12 (-2.88%)

Dinner Meeting to be held…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Lantheus sees FY20 adj. EPS $1.34-$1.40, consensus $1.03 » 07:16
02/25/20
02/25
07:16
02/25/20
07:16
LNTH

Lantheus

$16.11 /

-0.46 (-2.78%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Chimerix reports Q4 EPS (6c), two est. (17c) » 07:16
02/25/20
02/25
07:16
02/25/20
07:16
CMRX

Chimerix

$1.75 /

+0.025 (+1.45%)

Reports Q4 revenue $6.8M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Aeglea BioTherapeutics price target raised to $24 from $20 at H.C. Wainwright » 07:16
02/25/20
02/25
07:16
02/25/20
07:16
AGLE

Aeglea BioTherapeutics

$7.42 /

-0.42 (-5.36%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
United Therapeutics price target raised to $243 from $237 at Wedbush » 07:15
02/25/20
02/25
07:15
02/25/20
07:15
UTHR

United Therapeutics

$115.29 /

+8.33 (+7.79%)

Wedbush analyst Liana…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Nutrien announces TSX approval for renewed share repurchase program » 07:15
02/25/20
02/25
07:15
02/25/20
07:15
NTR

Nutrien

$42.02 /

-0.555 (-1.30%)

Nutrien announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Epizyme price target raised to $36 from $25 at H.C. Wainwright » 07:14
02/25/20
02/25
07:14
02/25/20
07:14
EPZM

Epizyme

$21.65 /

-3.24 (-13.02%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Lantheus sees Q1 adj. EPS 25c-27c, one estimate 3c » 07:14
02/25/20
02/25
07:14
02/25/20
07:14
LNTH

Lantheus

$16.11 /

-0.46 (-2.78%)

Sees Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Proteostasis announces publication of of nonclinical data on PTI-428 » 07:14
02/25/20
02/25
07:14
02/25/20
07:14
PTI

Proteostasis

$1.94 /

-0.05 (-2.51%)

Proteostasis Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.